Avid Bioservices Inc (CDMO)
6.82
+0.15
(+2.25%)
USD |
NASDAQ |
Apr 24, 16:00
6.82
0.00 (0.00%)
After-Hours: 20:00
Avid Bioservices EPS Diluted (Quarterly): -0.15 for Oct. 31, 2023
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
Date | Value |
---|---|
October 31, 2023 | -0.15 |
July 31, 2023 | -0.03 |
April 30, 2023 | -0.0049 |
January 31, 2023 | 0.01 |
October 31, 2022 | -0.02 |
July 31, 2022 | 0.02 |
April 30, 2022 | 1.65 |
January 31, 2022 | 0.04 |
October 31, 2021 | 0.06 |
July 31, 2021 | 0.10 |
April 30, 2021 | -0.04 |
January 31, 2021 | 0.01 |
October 31, 2020 | 0.01 |
July 31, 2020 | 0.06 |
April 30, 2020 | -0.11 |
January 31, 2020 | -0.06 |
October 31, 2019 | -0.03 |
July 31, 2019 | -0.08 |
April 30, 2019 | -0.02 |
January 31, 2019 | -0.05 |
October 31, 2018 | -0.05 |
July 31, 2018 | -0.06 |
April 30, 2018 | 0.03 |
January 31, 2018 | -0.28 |
October 31, 2017 | -0.31 |
Date | Value |
---|---|
July 31, 2017 | -0.06 |
April 30, 2017 | -0.16 |
January 31, 2017 | -0.25 |
October 31, 2016 | -0.16 |
July 31, 2016 | -0.36 |
April 30, 2016 | -0.34 |
January 31, 2016 | -0.56 |
October 31, 2015 | -0.49 |
July 31, 2015 | -0.56 |
April 30, 2015 | -0.46 |
January 31, 2015 | -0.56 |
October 31, 2014 | -0.49 |
July 31, 2014 | -0.56 |
April 30, 2014 | -0.42 |
January 31, 2014 | -0.42 |
October 31, 2013 | -0.35 |
July 31, 2013 | -0.35 |
April 30, 2013 | -0.42 |
January 31, 2013 | -0.28 |
October 31, 2012 | -0.56 |
July 31, 2012 | -0.49 |
April 30, 2012 | -0.70 |
January 31, 2012 | -0.91 |
October 31, 2011 | -1.12 |
July 31, 2011 | -0.77 |
Earnings per Share Definition
Earnings per share measures the total net income / average shares outstanding during income period. There are a few variations to earnings per share that are listed including "EPS Basic", "EPS Diluted", "Normalized Basic EPS", and "Normalized Diluted EPS". Each of these metrics are dependent on which earnings and shares outstanding metrics are used. Basic and Diluted EPS differ in that diluted shares are the amount of shares outstanding after all convertible securities, options, and warrants are exercised. Normalized EPS allows does not include one-time expenses.
EPS Diluted (Quarterly) Range, Past 5 Years
-0.15
Minimum
Oct 2023
1.65
Maximum
Apr 2022
0.0745
Average
-0.0049
Median
Apr 2023
EPS Diluted (Quarterly) Benchmarks
Emergent BioSolutions Inc | -0.88 |
Creative Medical Technology Holdings Inc | -1.21 |
Viking Therapeutics Inc | -0.25 |
Stereotaxis Inc | -0.06 |
MAIA Biotechnology Inc | -0.41 |
EPS Diluted (Quarterly) Related Metrics
Net Income (Quarterly) | -9.509M |
Revenue (Quarterly) | 25.40M |
Total Expenses (Quarterly) | 36.62M |
Enterprise Value | 531.54M |
Gross Profit Margin (Quarterly) | -18.37% |
Profit Margin (Quarterly) | -37.44% |
Earnings Yield | -2.57% |
Normalized Earnings Yield | -2.565 |